An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option

G. Manzotti; F. Torricelli; D. Benedetta; F. Lococo; V. Sancisi; G. Rossi; S. Piana; A. Ciarrocchi

doi:10.1158/1078-0432.CCR-18-2364

An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option

G. Manzotti, F. Torricelli, D. Benedetta, F. Lococo, V. Sancisi, G. Rossi, S. Piana, A. Ciarrocchi

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2348-2360
Number of pages	13
Journal	Clinical Cancer Research
Volume	25
Issue number	7
DOIs	https://doi.org/10.1158/1078-0432.CCR-18-2364
Publication status	Published - 2019

Access to Document

10.1158/1078-0432.CCR-18-2364

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064179348&doi=10.1158%2f1078-0432.CCR-18-2364&partnerID=40&md5=9d625a9a8d1faa20aa69e324e74c7375

Cite this

Manzotti, G., Torricelli, F., Benedetta, D., Lococo, F., Sancisi, V., Rossi, G., Piana, S., & Ciarrocchi, A. (2019). An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option. Clinical Cancer Research, 25(7), 2348-2360. https://doi.org/10.1158/1078-0432.CCR-18-2364

An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option. / Manzotti, G.; Torricelli, F.; Benedetta, D.; Lococo, F.; Sancisi, V.; Rossi, G.; Piana, S.; Ciarrocchi, A.

In: Clinical Cancer Research, Vol. 25, No. 7, 2019, p. 2348-2360.

Research output: Contribution to journal › Article › peer-review

Manzotti, G , Torricelli, F, Benedetta, D, Lococo, F , Sancisi, V, Rossi, G, Piana, S & Ciarrocchi, A 2019, 'An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option', Clinical Cancer Research, vol. 25, no. 7, pp. 2348-2360. https://doi.org/10.1158/1078-0432.CCR-18-2364

@article{941131f1f35a40b09529ec50c9fde5e1,

title = "An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option",

author = "G. Manzotti and F. Torricelli and D. Benedetta and F. Lococo and V. Sancisi and G. Rossi and S. Piana and A. Ciarrocchi",

note = "Cited By :1 Export Date: 13 May 2019",

year = "2019",

doi = "10.1158/1078-0432.CCR-18-2364",

language = "English",

volume = "25",

pages = "2348--2360",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "7",

}

TY - JOUR

T1 - An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option

AU - Manzotti, G.

AU - Torricelli, F.

AU - Benedetta, D.

AU - Lococo, F.

AU - Sancisi, V.

AU - Rossi, G.

AU - Piana, S.

AU - Ciarrocchi, A.

N1 - Cited By :1 Export Date: 13 May 2019

PY - 2019

Y1 - 2019

U2 - 10.1158/1078-0432.CCR-18-2364

DO - 10.1158/1078-0432.CCR-18-2364

M3 - Article

VL - 25

SP - 2348

EP - 2360

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 7

ER -